A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy Participants

NCT04258189 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Janssen Research & Development, LLC